Intellia cuts 27% of staff, in the latest wave of gene-editing layoffs

Comments
Loading...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning! Ready for JPM? We’ll be on the ground and covering it in-depth next week. Please note: This newsletter will be dropping into your inbox in the afternoon instead of in the morning.

Read the rest…

Market News and Data brought to you by Benzinga APIs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!